
Glucosamine May Be Linked to Faster Dementia Progression, Study Finds
A study using anonymized UF Health records of about 24,000 dementia patients and 41,000 with mild cognitive impairment found glucosamine use associated with a 25% higher risk of death within five years for Alzheimer's patients and a 25% higher likelihood of progression from MCI to Alzheimer's. Mouse experiments suggested a mechanism involving brain sugar chains, but the study shows association, not causation, and dose, brand, and duration are unknown. The findings warrant caution for people with cognitive decline and call for controlled trials to establish causality.













